Roche gets double dose of good Hemlibra news with FDA breakthrough, ICER backing

Roche gets double dose of good Hemlibra news with FDA breakthrough, ICER backing

Source: 
Fierce Pharma
snippet: 

Roche is relying on hemophilia newcomer Hemlibra to crank out major sales, and the company got two pieces of good news on that front early this week.